Ubs Group Ag Castle Biosciences Inc Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Castle Biosciences Inc stock. As of the latest transaction made, Ubs Group Ag holds 26,400 shares of CSTL stock, worth $495,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,400

Previous 26,400 -0.0%

Holding current value

$495,000

Previous $752,000 6.52%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$26.52 - $34.67 $20.1 Million - $26.3 Million	758,466 Added 1401.09%	812,600 $21.7 Million
Q3 2024 Nov 14, 2024	BUY	$17.4 - $31.47 $94,151 - $170,284	5,411 Added 11.11%	54,134 $1.54 Million
Q2 2024 Aug 13, 2024	SELL	$18.84 - $24.94 $115,300 - $152,632	-6,120 Reduced 11.16%	48,723 $1.06 Million
Q1 2024 May 13, 2024	BUY	$18.06 - $25.3 $241,389 - $338,159	13,366 Added 32.23%	54,843 $1.21 Million
Q4 2023 Feb 09, 2024	BUY	$12.19 - $22.43 $285,684 - $525,669	23,436 Added 129.9%	41,477 $895,000
Q3 2023 Nov 09, 2023	BUY	$13.28 - $20.3 $9,774 - $14,940	736 Added 4.25%	18,041 $304,000
Q2 2023 Aug 11, 2023	BUY	$11.66 - $26.0 $78,483 - $175,006	6,731 Added 63.66%	17,305 $237,000
Q1 2023 May 12, 2023	BUY	$19.47 - $28.49 $1,732 - $2,535	89 Added 0.85%	10,574 $240,000
Q4 2022 Feb 08, 2023	BUY	$18.08 - $30.0 $60,640 - $100,620	3,354 Added 47.03%	10,485 $246,000
Q3 2022 Nov 10, 2022	SELL	$22.51 - $34.32 $204,705 - $312,106	-9,094 Reduced 56.05%	7,131 $186,000
Q2 2022 Aug 10, 2022	BUY	$16.0 - $45.99 $198,016 - $569,172	12,376 Added 321.54%	16,225 $356,000
Q1 2022 May 16, 2022	SELL	$33.17 - $46.98 $217,230 - $307,672	-6,549 Reduced 62.98%	3,849 $173,000
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $357,086 - $617,816	9,142 Added 727.87%	10,398 $446,000
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $34,634 - $44,697	576 Added 84.71%	1,256 $83,000
Q2 2021 Aug 13, 2021	SELL	$50.07 - $76.78 $425,444 - $652,399	-8,497 Reduced 92.59%	680 $50,000
Q1 2021 May 12, 2021	SELL	$58.92 - $97.33 $115,836 - $191,350	-1,966 Reduced 17.64%	9,177 $628,000
Q4 2020 Feb 11, 2021	BUY	$43.6 - $73.05 $310,475 - $520,189	7,121 Added 177.05%	11,143 $748,000
Q3 2020 Nov 12, 2020	SELL	$38.47 - $52.03 $85,749 - $115,974	-2,229 Reduced 35.66%	4,022 $206,000
Q2 2020 Jul 31, 2020	SELL	$27.28 - $43.01 $11,784 - $18,580	-432 Reduced 6.46%	6,251 $236,000
Q1 2020 May 01, 2020	BUY	$23.08 - $35.53 $34,389 - $52,939	1,490 Added 28.69%	6,683 $199,000
Q4 2019 Feb 14, 2020	BUY	$15.74 - $35.04 $37,508 - $83,500	2,383 Added 84.8%	5,193 $178,000
Q3 2019 Nov 14, 2019	BUY	$18.09 - $27.92 $50,832 - $78,455	2,810 New	2,810 $51,000

Others Institutions Holding CSTL

# of Institutions

204

Shares Held

26.2M

Call Options Held

128K

Put Options Held

35.4K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $493M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account